102 related articles for article (PubMed ID: 25354938)
1. Involvement of neutral sphingomyelinase in the angiotensin II signaling pathway.
Bautista-Pérez R; del Valle-Mondragón L; Cano-Martínez A; Pérez-Méndez O; Escalante B; Franco M
Am J Physiol Renal Physiol; 2015 May; 308(10):F1178-87. PubMed ID: 25354938
[TBL] [Abstract][Full Text] [Related]
2. Ceramide inhibits Kv currents and contributes to TP-receptor-induced vasoconstriction in rat and human pulmonary arteries.
Moral-Sanz J; Gonzalez T; Menendez C; David M; Moreno L; Macias A; Cortijo J; Valenzuela C; Perez-Vizcaino F; Cogolludo A
Am J Physiol Cell Physiol; 2011 Jul; 301(1):C186-94. PubMed ID: 21490312
[TBL] [Abstract][Full Text] [Related]
3. Afferent arteriolar responses to ANG II involve activation of PLA2 and modulation by lipoxygenase and P-450 pathways.
Imig JD; Deichmann PC
Am J Physiol; 1997 Aug; 273(2 Pt 2):F274-82. PubMed ID: 9277588
[TBL] [Abstract][Full Text] [Related]
4. Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells.
Muthalif MM; Benter IF; Uddin MR; Harper JL; Malik KU
J Pharmacol Exp Ther; 1998 Jan; 284(1):388-98. PubMed ID: 9435202
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II and thromboxane in the regulation of blood pressure and renal function.
Wilcox CS; Welch WJ
Kidney Int Suppl; 1990 Nov; 30():S81-3. PubMed ID: 2259083
[TBL] [Abstract][Full Text] [Related]
6. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
Muller C; Endlich K; Barthelmebs M; Helwig JJ
Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II constriction of rat vasa recta is partially thromboxane dependent.
Silldorff EP; Hilbun LR; Pallone TL
Hypertension; 2002 Oct; 40(4):541-6. PubMed ID: 12364360
[TBL] [Abstract][Full Text] [Related]
8. High glucose down-regulates angiotensin II binding via the PKC-MAPK-cPLA2 signal cascade in renal proximal tubule cells.
Park SH; Woo CH; Kim JH; Lee JH; Yang IS; Park KM; Han HJ
Kidney Int; 2002 Mar; 61(3):913-25. PubMed ID: 11849446
[TBL] [Abstract][Full Text] [Related]
9. AT2 antagonist-sensitive potentiation of angiotensin II-induced constriction by NO blockade and its dependence on endothelium and P450 eicosanoids in rat renal vasculature.
Muller C; Endlich K; Helwig JJ
Br J Pharmacol; 1998 Jul; 124(5):946-52. PubMed ID: 9692780
[TBL] [Abstract][Full Text] [Related]
10. Lipids and nitric oxide in porcine retinal and choroidal blood vessels.
Kulkarni P; Cai J; Hurst HE
J Ocul Pharmacol Ther; 2002 Jun; 18(3):265-75. PubMed ID: 12099547
[TBL] [Abstract][Full Text] [Related]
11. Short-term ANG II produces renal vasoconstriction independent of TP receptor activation and TxA2/isoprostane production.
Vågnes ØB; Iversen BM; Arendshorst WJ
Am J Physiol Renal Physiol; 2007 Sep; 293(3):F860-7. PubMed ID: 17567934
[TBL] [Abstract][Full Text] [Related]
12. Thromboxane A2/prostaglandin H2 receptor activation mediates angiotensin II-induced postischemic neovascularization.
Michel F; Silvestre JS; Waeckel L; Corda S; Verbeuren T; Vilaine JP; Clergue M; Duriez M; Levy BI
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):488-93. PubMed ID: 16385086
[TBL] [Abstract][Full Text] [Related]
13. Oligomer formation of Clostridium perfringens epsilon-toxin is induced by activation of neutral sphingomyelinase.
Takagishi T; Oda M; Takehara M; Kobayashi K; Nagahama M
Biochim Biophys Acta; 2016 Nov; 1858(11):2681-2688. PubMed ID: 27453200
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II-dependent growth of vascular smooth muscle cells requires transactivation of the epidermal growth factor receptor via a cytosolic phospholipase A(2)-mediated release of arachidonic acid.
Freeman EJ; Sheakley ML; Clements RJ
Arch Biochem Biophys; 2010 Jun; 498(1):50-6. PubMed ID: 20388488
[TBL] [Abstract][Full Text] [Related]
15. Arachidonic acid metabolites inhibit the stimulatory effect of angiotensin II in renal proximal tubules.
Li Y; Yamada H; Kita Y; Suzuki M; Endo Y; Horita S; Yamazaki O; Shimizu T; Seki G; Fujita T
Hypertens Res; 2008 Dec; 31(12):2155-64. PubMed ID: 19139605
[TBL] [Abstract][Full Text] [Related]
16. Role of shear stress in nitric oxide-dependent modulation of renal angiotensin II vasoconstriction.
Endlich K; Muller C; Barthelmebs M; Helwig JJ
Br J Pharmacol; 1999 Aug; 127(8):1929-35. PubMed ID: 10482926
[TBL] [Abstract][Full Text] [Related]
17. Role of eicosanoids in renal angiotensin II vasoconstriction during nitric oxide blockade.
Muller C; Endlich K; Helwig JJ
Kidney Int Suppl; 1998 Sep; 67():S234-7. PubMed ID: 9736302
[TBL] [Abstract][Full Text] [Related]
18. Effects of angiotensin II, arginine vasopressin and tromboxane A2 in renal vascular bed: role of rho-kinase.
Cavarape A; Bauer J; Bartoli E; Endlich K; Parekh N
Nephrol Dial Transplant; 2003 Sep; 18(9):1764-9. PubMed ID: 12937222
[TBL] [Abstract][Full Text] [Related]
19. Orchidectomy modulates alpha2-adrenoceptor reactivity in rat mesenteric artery through increased thromboxane A2 formation.
Blanco-Rivero J; Balfagón G; Ferrer M
J Vasc Res; 2006; 43(1):101-8. PubMed ID: 16293968
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism.
Rodríguez A; Fortuño A; Gómez-Ambrosi J; Zalba G; Díez J; Frühbeck G
Endocrinology; 2007 Jan; 148(1):324-31. PubMed ID: 17038553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
